Vivien Sheehan
Pediatric Hematology-Oncology · Atlanta, GANPI 1306054812
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,061 of the $50,526 with a category attached, or 63.5%. 19 manufacturers reported payments, led by Emmaus Medical, Inc. at 28.1% of the total. Reporting peaked in 2019 at $14,547 and has fallen 80.7% since, to $2,813 in 2025. Among pediatric hematology-oncology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $765.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Emmaus Medical, Inc.$14K
- Novo Nordisk Health Care AG$13K
- Vertex$8K
- Pfizer$3K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Sanofi US Services Inc.$3K
- plus $6K from 13 others
Across 40 payments — averaging $37,237 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Global Blood Therapeutics, Inc.$719K
- Pfizer$567K
- Novartis$87K
- Agios Pharmaceuticals, Inc.$82K
- Emmaus Medical, Inc.$35K
What the payments were for
- Consulting fees$32,06163%
- Speaking & faculty fees$2,8136%
- Travel & lodging$11,85123%
- Food & beverage$2,4415%
- Education$1,3603%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Emmaus Medical, Inc. | 6 | $14,202 |
| Novo Nordisk Health Care AG | 4 | $13,270 |
| Vertex | 11 | $8,197 |
| Pfizer | 6 | $3,205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $2,833 |
| Sanofi US Services Inc. | 1 | $2,725 |
| Novo Nordisk AS | 2 | $2,620 |
| Novartis | 11 | $1,562 |
| Agios Pharmaceuticals, Inc. | 12 | $810 |
| AstraZeneca | 1 | $560 |
| Global Blood Therapeutics, Inc. | 2 | $192 |
| Genetix Biotherapeutics Inc | 1 | $134 |
| Novo Nordisk | 1 | $124 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Incyte Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$50,526 in reported general payments places this provider in the 90th percentile of 74 pediatric hematology-oncology providers in Georgia.
See all pediatric hematology-oncology providers in Georgia →
Other pediatric hematology-oncology in Atlanta
- Robert SidonioAtlanta$834K
- Shannon MeeksAtlanta$255K
- Bhavya DoshiAtlanta$200K
- Muna QayedAtlanta$86K
- Shanmuganathan ChandrakasanAtlanta$67K
- Carlton DampierAtlanta$30K
- William CashAtlanta$28K
- Megan BrownAtlanta$24K
- Lakshmanan KrishnamurtiAtlanta$22K
- Carolyn BennettAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.